Literature DB >> 20829826

Biopharmaceutical benchmarks 2010.

Gary Walsh1.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20829826     DOI： 10.1038/nbt0910-917

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  21 in total

1.  Fresh from the biologic pipeline-2009.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2010-04       Impact factor: 54.908

2.  Biopharmaceutical benchmarks 2006.

Authors:  Gary Walsh
Journal:  Nat Biotechnol       Date:  2006-07       Impact factor: 54.908

Review 3.  Post-translational modifications in the context of therapeutic proteins.

Authors:  Gary Walsh; Roy Jefferis
Journal:  Nat Biotechnol       Date:  2006-10       Impact factor: 54.908

Review 4.  Selection methods for high-producing mammalian cell lines.

Authors:  Susan M Browne; Mohamed Al-Rubeai
Journal:  Trends Biotechnol       Date:  2007-07-30       Impact factor: 19.536

5.  Toward biosimilar monoclonal antibodies.

Authors:  Christian K Schneider; Ulrich Kalinke
Journal:  Nat Biotechnol       Date:  2008-09       Impact factor: 54.908

6.  Certolizumab pegol.

Authors:  Gil Y Melmed; Stephan R Targan; Uma Yasothan; Delphine Hanicq; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2008-08       Impact factor: 84.694

7.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

Review 8.  Expression systems for therapeutic glycoprotein production.

Authors:  Yves Durocher; Michael Butler
Journal:  Curr Opin Biotechnol       Date:  2009-11-04       Impact factor: 9.740

9.  Novel long-lasting interferon alpha derivatives designed by glycoengineering.

Authors:  N Ceaglio; M Etcheverrigaray; R Kratje; M Oggero
Journal:  Biochimie       Date:  2007-11-05       Impact factor: 4.079

10.  Efficacy of native and hyperglycosylated follicle-stimulating hormone analogs for promoting fertility in female mice.

Authors:  Rhonda K Trousdale; Bo Yu; Susan V Pollak; Nabil Husami; Andrea Vidali; Joyce W Lustbader
Journal:  Fertil Steril       Date:  2008-02-04       Impact factor: 7.329
View more
  171 in total

Review 1.  Genomics in mammalian cell culture bioprocessing.

Authors:  Diane M Wuest; Sarah W Harcum; Kelvin H Lee
Journal:  Biotechnol Adv       Date:  2011-11-04       Impact factor: 14.227

Review 2.  Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets.

Authors:  Pauline L Martin; Peter J Bugelski
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 3.  Therapeutic proteins.

Authors:  Dimiter S Dimitrov
Journal:  Methods Mol Biol       Date:  2012

4.  Functional single-cell hybridoma screening using droplet-based microfluidics.

Authors:  Bachir El Debs; Ramesh Utharala; Irina V Balyasnikova; Andrew D Griffiths; Christoph A Merten
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

Review 5.  Regenerative medicine: Current therapies and future directions.

Authors:  Angelo S Mao; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-24       Impact factor: 11.205

Review 6.  The transgenic animal platform for biopharmaceutical production.

Authors:  L R Bertolini; H Meade; C R Lazzarotto; L T Martins; K C Tavares; M Bertolini; J D Murray
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

Review 7.  Protein particulate detection issues in biotherapeutics development--current status.

Authors:  Tapan K Das
Journal:  AAPS PharmSciTech       Date:  2012-05-08       Impact factor: 3.246

8.  Traceability of biopharmaceuticals in spontaneous reporting systems: a cross-sectional study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databases.

Authors:  Niels S Vermeer; Sabine M J M Straus; Aukje K Mantel-Teeuwisse; Francois Domergue; Toine C G Egberts; Hubert G M Leufkens; Marie L De Bruin
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

Review 9.  Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.

Authors:  Aleš Berlec; Borut Strukelj
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

10.  The GalNAc-type O-Glycoproteome of CHO cells characterized by the SimpleCell strategy.

Authors:  Zhang Yang; Adnan Halim; Yoshiki Narimatsu; Hiren Jitendra Joshi; Catharina Steentoft; Katrine Ter-Borch Gram Schjoldager; Morten Alder Schulz; Natalie R Sealover; Kevin J Kayser; Eric Paul Bennett; Steven B Levery; Sergey Y Vakhrushev; Henrik Clausen
Journal:  Mol Cell Proteomics       Date:  2014-08-04       Impact factor: 5.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.